Global Ventricular Assist Devices Market Overview:

The latest report by IMARC Group, titled “Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the ventricular assist devices market forecast. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global ventricular assist devices market size reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027.

A ventricular assist device (VAD), also called a mechanical circulatory support device, represents a mechanical pump that helps to transport blood from the lower chambers of the heart to all body parts. It comprises of three components, which include tubes, an electronic controller, and a power source. A ventricular assist device is implanted in patients for short-term treatments to support heart functions post-surgery. It finds various applications in the bridge-to-transplant (BTT), bridge-to-recovery (BTR), bridge-to-candidacy (BTC), and destination therapies. Ventricular assist devices are widely utilized in medical laboratories, research centers, hospitals, clinics, etc., across the globe.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally-our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/ventricular-assist-devices-market/requestsample

Table of Contents

Global Ventricular Assist Devices Market Trends:

The growing incidences of several cardiovascular diseases and disorders, including hypertension, ventricular septal defect, heart failure, etc., are among the key factors driving the ventricular assist devices market. In addition to this, the limited number of existing heart donors is escalating the demand for VADs, which is further propelling the market growth.

Moreover, various leading manufacturers in the healthcare industry are incorporating technological advancements, such as miniature devices with infection control technology, to address several complications, including the high risk of infection, thrombus formation, blood trauma, etc. This, in turn, is also positively influencing the global market. Apart from this, numerous clinical trials are being undertaken to enhance the survival rate of patients by improving the durability, functionality, efficiency, etc., of VADs, which is expected to fuel the ventricular assist devices market over the forecasted period.